Asia-Pacific Nuclear Medicine Diagnostics Market By Application (cardiology, Lymphoma, Thyroid, Neurology, Oncology)
Asia-Pacific nuclear medicine diagnostic market is estimated at $2.01 billion in 2018 and is poised to reach $3.86 billion by 2023, at a CAGR of 13.9%
(EMAILWIRE.COM, August 27, 2018 ) Nuclear medicine is a branch of medicine that utilizes radiation to convey data about the working of a person's particular organs to treat a disease. As a rule, the data will help the doctors to make a fast, precise diagnosis of the patient's disease.Till now, SPECT imaging was the most customary modality for nuclear medicine applications, for example, nuclear cardiology methods. Be that as it may, the pattern is soon going to see a down turn inferable from lack of molybdenum-99 isotope which thus will prompt insufficiency of Technetium-99, which is the side-product of molybdenum. Subsequently, PET imaging items which incorporate PET-CT scanners is assessed to be the quickest developing and anticipated that it will represent a conceivably strong share soon.
This developing business sector liking is going to be a combination of nuclear imaging with various diagnostic imaging items, for example, SPECT/CT, PET/CT and MRI/PET. This gives full range of imaging scans over a similar unit and in the same time. PET market is expected to witness more growth when compared to SPECT imaging because of its better features of conveying higher resolution pictures and the absence of accessibility of technetium-99m.
Get a comprehensive overview of the Asia-Pacific Nuclear Medicine Diagnostics Market: http://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-medicine-diagnostics-market-126/
Asia-Pacific Nuclear Medicine Diagnostics Market: Drivers & Restraints
Expanding utilization of SPECT and PET in medical diagnostics, growing awareness among individuals about radiopharmaceuticals, and ready accessibility of radiopharmaceuticals are few of the main factors fuelling the development of the market. However, shorter half-life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are a few limitations for the nuclear medicine market growth.
Get accurate market forecast and analysis on the Asia-Pacific Nuclear Medicine Diagnostics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-medicine-diagnostics-market-126/request-sample
Asia-Pacific Nuclear Medicine Diagnostics Market: Segmentation
By Type
SPECT
Technetium-99m
Thallium-201
Gallium-67
Iodine-23
Others
PET
Fluorine-18
Rubidium-82
Others
By Application
Cardiology
Lymphoma
Thyroid
Neurology
Oncology
Others
From simple data collection through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-medicine-diagnostics-market-126/customize-report
Asia-Pacific Nuclear Medicine Diagnostics Market: Overview
In this market, the factors which influence the growth positively are increasing incidence of cancer and cardiac diseases. The most common modality for nuclear medicine is SPECT Imaging, for applications such as nuclear cardiology methods. Asia-Pacific has the second largest market share globally in this sector and has the highest growth rate.
Asia-Pacific Nuclear Medicine Diagnostics Market: Region-wise Outlook
On the basis of geography, the Asia-Pacific market is analyzed under the regions India, China, Australia, Thailand and Philippines. Nuclear Medicine Diagnostics Market is dominated by China in this region. Growth of the Asia-Pacific Market is primarily driven by factors like increasing awareness, growing utilization of SPECT and PET in medical diagnostics, redy accessibility of them among others.
Key Questions Answered
What is the current and future Nuclear Medicine Diagnostics market outlook in Asia-Pacific? What trends are affecting the Asia-Pacific market?
What is the competitive landscape and market share of major players in the Nuclear Medicine Diagnostics market in Asia-Pacific?
What are the key market segments that currently occupy the highest market share? Which market segments are growing the fastest?
What challenges are restraining the growth of the Nuclear Medicine Diagnostics market? How will emerging technologies answer these challenges?
What is physician perception and market outlook of Nuclear Medicine Diagnostics?
Asia-Pacific Nuclear Medicine Diagnostics Market: Key Players
Major players in the market include Cardinal Health, Inc., Bracco Imaging S.p.A,GE Healthcare,Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc.,Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.
Reasons to buy Asia-Pacific Nuclear Medicine Diagnostics Market Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
This developing business sector liking is going to be a combination of nuclear imaging with various diagnostic imaging items, for example, SPECT/CT, PET/CT and MRI/PET. This gives full range of imaging scans over a similar unit and in the same time. PET market is expected to witness more growth when compared to SPECT imaging because of its better features of conveying higher resolution pictures and the absence of accessibility of technetium-99m.
Get a comprehensive overview of the Asia-Pacific Nuclear Medicine Diagnostics Market: http://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-medicine-diagnostics-market-126/
Asia-Pacific Nuclear Medicine Diagnostics Market: Drivers & Restraints
Expanding utilization of SPECT and PET in medical diagnostics, growing awareness among individuals about radiopharmaceuticals, and ready accessibility of radiopharmaceuticals are few of the main factors fuelling the development of the market. However, shorter half-life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are a few limitations for the nuclear medicine market growth.
Get accurate market forecast and analysis on the Asia-Pacific Nuclear Medicine Diagnostics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-medicine-diagnostics-market-126/request-sample
Asia-Pacific Nuclear Medicine Diagnostics Market: Segmentation
By Type
SPECT
Technetium-99m
Thallium-201
Gallium-67
Iodine-23
Others
PET
Fluorine-18
Rubidium-82
Others
By Application
Cardiology
Lymphoma
Thyroid
Neurology
Oncology
Others
From simple data collection through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-medicine-diagnostics-market-126/customize-report
Asia-Pacific Nuclear Medicine Diagnostics Market: Overview
In this market, the factors which influence the growth positively are increasing incidence of cancer and cardiac diseases. The most common modality for nuclear medicine is SPECT Imaging, for applications such as nuclear cardiology methods. Asia-Pacific has the second largest market share globally in this sector and has the highest growth rate.
Asia-Pacific Nuclear Medicine Diagnostics Market: Region-wise Outlook
On the basis of geography, the Asia-Pacific market is analyzed under the regions India, China, Australia, Thailand and Philippines. Nuclear Medicine Diagnostics Market is dominated by China in this region. Growth of the Asia-Pacific Market is primarily driven by factors like increasing awareness, growing utilization of SPECT and PET in medical diagnostics, redy accessibility of them among others.
Key Questions Answered
What is the current and future Nuclear Medicine Diagnostics market outlook in Asia-Pacific? What trends are affecting the Asia-Pacific market?
What is the competitive landscape and market share of major players in the Nuclear Medicine Diagnostics market in Asia-Pacific?
What are the key market segments that currently occupy the highest market share? Which market segments are growing the fastest?
What challenges are restraining the growth of the Nuclear Medicine Diagnostics market? How will emerging technologies answer these challenges?
What is physician perception and market outlook of Nuclear Medicine Diagnostics?
Asia-Pacific Nuclear Medicine Diagnostics Market: Key Players
Major players in the market include Cardinal Health, Inc., Bracco Imaging S.p.A,GE Healthcare,Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc.,Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.
Reasons to buy Asia-Pacific Nuclear Medicine Diagnostics Market Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results